Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
40,225,592
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
29,075,127
-
Shares change
-
+609,109
-
Total reported value, excl. options
-
$539,323,483
-
Value change
-
+$6,162,761
-
Number of buys
-
42
-
Number of sells
-
32
-
Price
-
$18.49
Institutional Holders of ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) as of Q1 2025
As of 31 Mar 2025 ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 29,075,127 shares of stock of the company.
Largest 10 holders included HHLR ADVISORS, LTD., ORBIMED ADVISORS LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., FMR LLC, INFINITUM ASSET MANAGEMENT, LLC, Octagon Capital Advisors LP, Novo Holdings A/S, Sofinnova Investments, Inc., and VANGUARD GROUP INC.
This table shows 82 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.